{"transactions":[{"id":731754,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":36721,"kind":"person","name":"Stergiou Angelos M.","position":1,"cik":"0001724253","reported_name":"Stergiou Angelos M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-06-18T20:30:24.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":1065000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 1,065,000 restricted stock units on June 16, 2026, which shall vest as follows: (i) 25% on December 1, 2026 and (ii) 25% on each December 1 thereafter until fully\nvested, provided that the Reporting Person remains in service with the Issuer through each such vesting date."}],"balance_after":1759183,"source":{"system":"sec-edgar","filing":"0001104659-26-075773","document":"tm2618312-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465926075773/tm2618312-1_4seq1.xml","form_type":"4"}},{"id":941894,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69637,"kind":"person","name":"CICIC DRAGAN","position":1,"cik":"0001565795","reported_name":"CICIC DRAGAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-01-09T21:35:34.000Z","date":"2026-01-07","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 300,000 restricted stock units on January 7, 2026, which shall vest as follows: (i) 25% on December 1, 2026 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date."}],"balance_after":557805,"source":{"system":"sec-edgar","filing":"0001104659-26-002506","document":"tm262627-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465926002506/tm262627-4_4seq1.xml","form_type":"4"}},{"id":941895,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69638,"kind":"person","name":"Burns John Thomas","position":1,"cik":"0001568734","reported_name":"Burns John Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-01-09T21:33:13.000Z","date":"2026-01-07","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 300,000 restricted stock units on January 7, 2026, which shall vest as follows: (i) 25% on December 1, 2026 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date."}],"balance_after":554327,"source":{"system":"sec-edgar","filing":"0001104659-26-002502","document":"tm262627-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465926002502/tm262627-3_4seq1.xml","form_type":"4"}},{"id":941893,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69636,"kind":"person","name":"Kalin Katherine Bach","position":1,"cik":"0001832671","reported_name":"Kalin Katherine Bach","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-09T21:31:37.000Z","date":"2026-01-07","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 50,000 restricted stock units on January 7, 2026, which shall vest in full on December 1, 2026, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":154400,"source":{"system":"sec-edgar","filing":"0001104659-26-002499","document":"tm262627-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465926002499/tm262627-2_4seq1.xml","form_type":"4"}},{"id":941897,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":46095,"kind":"person","name":"Wasman Jane","position":1,"cik":"0001352455","reported_name":"Wasman Jane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-09T21:30:18.000Z","date":"2026-01-07","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 50,000 restricted stock units on January 7, 2026, which shall vest in full on December 1, 2026, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":92900,"source":{"system":"sec-edgar","filing":"0001104659-26-002491","document":"tm262627-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1352455/000110465926002491/tm262627-1_4seq1.xml","form_type":"4"}},{"id":942035,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69656,"kind":"person","name":"Varian John","position":1,"cik":"0001416176","reported_name":"Varian John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-09T16:43:43.000Z","date":"2026-01-07","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 50,000 restricted stock units on January 7, 2026, which shall vest in full on December 1, 2026, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":72900,"source":{"system":"sec-edgar","filing":"0001104659-26-002515","document":"tm262627-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1416176/000110465926002515/tm262627-7_4seq1.xml","form_type":"4"}},{"id":941921,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69643,"kind":"person","name":"VAN NOSTRAND ROBERT L","position":1,"cik":"0001225198","reported_name":"VAN NOSTRAND ROBERT L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-09T16:39:03.000Z","date":"2026-01-07","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 50,000 restricted stock units on January 7, 2026, which shall vest in full on December 1, 2026, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":82900,"source":{"system":"sec-edgar","filing":"0001104659-26-002511","document":"tm262627-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1225198/000110465926002511/tm262627-6_4seq1.xml","form_type":"4"}},{"id":941920,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69642,"kind":"person","name":"SCHEINBERG DAVID A","position":1,"cik":"0001250316","reported_name":"SCHEINBERG DAVID A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-09T16:38:00.000Z","date":"2026-01-07","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 50,000 restricted stock units on January 7, 2026, which shall vest in full on December 1, 2026, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":73082,"source":{"system":"sec-edgar","filing":"0001104659-26-002509","document":"tm262627-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250316/000110465926002509/tm262627-5_4seq1.xml","form_type":"4"}},{"id":978803,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69637,"kind":"person","name":"CICIC DRAGAN","position":1,"cik":"0001565795","reported_name":"CICIC DRAGAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-12-05T21:07:39.000Z","date":"2025-12-03","kind":"other","planned":false,"acquired":false,"shares":63800,"price":1.5,"value":95700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction relates to shares of common stock withheld by the SELLAS Life Sciences Group, Inc. (the \"Issuer\") to cover tax withholding obligations of the Reporting Person in connection with the vesting of Restricted Stock Units (\"RSUs\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number shares of common stock withheld by the Issuer to cover tax withholding obligations of the Reporting Person in connection with the vesting of RSUs."}],"balance_after":257805,"source":{"system":"sec-edgar","filing":"0001104659-25-118882","document":"tm2532693-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465925118882/tm2532693-3_4seq1.xml","form_type":"4"}},{"id":978801,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69638,"kind":"person","name":"Burns John Thomas","position":1,"cik":"0001568734","reported_name":"Burns John Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-12-05T21:05:39.000Z","date":"2025-12-03","kind":"other","planned":false,"acquired":false,"shares":58592,"price":1.5,"value":87888.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction relates to shares of common stock withheld by the SELLAS Life Sciences Group, Inc. (the \"Issuer\") to cover tax withholding obligations of the Reporting Person in connection with the vesting of Restricted Stock Units (\"RSUs\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number shares of common stock withheld by the Issuer to cover tax withholding obligations of the Reporting Person in connection with the vesting of RSUs."}],"balance_after":254327,"source":{"system":"sec-edgar","filing":"0001104659-25-118878","document":"tm2532693-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465925118878/tm2532693-2_4seq1.xml","form_type":"4"}},{"id":978800,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":36721,"kind":"person","name":"Stergiou Angelos M.","position":1,"cik":"0001724253","reported_name":"Stergiou Angelos M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-12-05T21:05:13.000Z","date":"2025-12-03","kind":"other","planned":false,"acquired":false,"shares":187066,"price":1.5,"value":280599.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction relates to shares of common stock withheld by the SELLAS Life Sciences Group, Inc. (the \"Issuer\") to cover tax withholding obligations of the Reporting Person in connection with the vesting of Restricted Stock Units (\"RSUs\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number shares of common stock withheld by the Issuer to cover tax withholding obligations of the Reporting Person in connection with the vesting of RSUs."}],"balance_after":686966,"source":{"system":"sec-edgar","filing":"0001104659-25-118872","document":"tm2532693-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465925118872/tm2532693-1_4seq1.xml","form_type":"4"}},{"id":991104,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69636,"kind":"person","name":"Kalin Katherine Bach","position":1,"cik":"0001832671","reported_name":"Kalin Katherine Bach","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-21T13:45:10.000Z","date":"2025-11-19","kind":"purchase","planned":false,"acquired":true,"shares":63400,"price":1.59,"value":100806.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reflects the weighted average purchase price of the shares of common stock purchased. These shares of common stock were purchased in multiple transactions at prices ranging from $1.555 to $1.625 per share. Ms. Kalin undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of common stock purchased at each price."}],"balance_after":104400,"source":{"system":"sec-edgar","filing":"0001104659-25-114806","document":"tm2531880-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465925114806/tm2531880-1_4seq1.xml","form_type":"4"}},{"id":1111257,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69643,"kind":"person","name":"VAN NOSTRAND ROBERT L","position":1,"cik":"0001225198","reported_name":"VAN NOSTRAND ROBERT L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-13T08:00:33.000Z","date":"2025-06-12","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.48,"value":14800.0,"ownership":{"direct":true},"balance_after":20400,"source":{"system":"sec-edgar","filing":"0001104659-25-059166","document":"tm2517920-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1225198/000110465925059166/tm2517920-1_4seq1.xml","form_type":"4"}},{"id":1127319,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":46095,"kind":"person","name":"Wasman Jane","position":1,"cik":"0001352455","reported_name":"Wasman Jane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-02T20:42:07.000Z","date":"2025-05-30","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":1.69,"value":33800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in multiple transactions at a price of $1.69. The reporting person undertakes to provide SELLAS Life Sciences Group, Inc., any security holder of SELLAS Life Sciences Group, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at the price set forth in this footnote."}],"balance_after":30400,"source":{"system":"sec-edgar","filing":"0001104659-25-055495","document":"tm2516957-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1352455/000110465925055495/tm2516957-1_4seq1.xml","form_type":"4"}},{"id":1136751,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69636,"kind":"person","name":"Kalin Katherine Bach","position":1,"cik":"0001832671","reported_name":"Kalin Katherine Bach","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-22T20:05:17.000Z","date":"2025-05-22","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":1.8,"value":36000.0,"ownership":{"direct":true},"balance_after":41000,"source":{"system":"sec-edgar","filing":"0001104659-25-051980","document":"tm2515989-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465925051980/tm2515989-1_4seq1.xml","form_type":"4"}},{"id":1303229,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69638,"kind":"person","name":"Burns John Thomas","position":1,"cik":"0001568734","reported_name":"Burns John Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-14T22:34:56.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":169500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-quarter (1/4) of the option shares will vest and became exercisable one year from the January 10, 2025 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":169500,"derivative":{"exercise_price":0.9525,"expiration_date":"2035-01-10","underlying":"Common Stock","underlying_shares":169500},"source":{"system":"sec-edgar","filing":"0001104659-25-003502","document":"tm253166-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465925003502/tm253166-8_4seq1.xml","form_type":"4"}},{"id":1303228,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69638,"kind":"person","name":"Burns John Thomas","position":1,"cik":"0001568734","reported_name":"Burns John Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-01-14T22:34:56.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":81300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Reporting Person received an award of 81,300 restricted stock units on January 10, 2025, which shall vest in full on December 1, 2025, provided that the Reporting Person remains in service with the Issuer through each such vesting date."}],"balance_after":299062,"source":{"system":"sec-edgar","filing":"0001104659-25-003502","document":"tm253166-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465925003502/tm253166-8_4seq1.xml","form_type":"4"}},{"id":1303227,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69638,"kind":"person","name":"Burns John Thomas","position":1,"cik":"0001568734","reported_name":"Burns John Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-01-14T22:34:56.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":113000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 113,000 restricted stock units on January 10, 2025, which shall vest as follows: (i) 25% on December 1, 2025 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date."}],"balance_after":217762,"source":{"system":"sec-edgar","filing":"0001104659-25-003502","document":"tm253166-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465925003502/tm253166-8_4seq1.xml","form_type":"4"}},{"id":1303225,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":36721,"kind":"person","name":"Stergiou Angelos M.","position":1,"cik":"0001724253","reported_name":"Stergiou Angelos M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-14T22:34:30.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":385750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-quarter (1/4) of the option shares will vest and became exercisable one year from the January 10, 2025 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":385750,"derivative":{"exercise_price":0.9525,"expiration_date":"2035-01-10","underlying":"Common Stock","underlying_shares":385750},"source":{"system":"sec-edgar","filing":"0001104659-25-003501","document":"tm253166-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465925003501/tm253166-7_4seq1.xml","form_type":"4"}},{"id":1303224,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":36721,"kind":"person","name":"Stergiou Angelos M.","position":1,"cik":"0001724253","reported_name":"Stergiou Angelos M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-01-14T22:34:30.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":243900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Reporting Person received an award of 243,900 restricted stock units on January 10, 2025, which shall vest in full on December 1, 2025, provided that the Reporting Person remains in service with the Issuer through each such vesting date."}],"balance_after":859032,"source":{"system":"sec-edgar","filing":"0001104659-25-003501","document":"tm253166-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465925003501/tm253166-7_4seq1.xml","form_type":"4"}},{"id":1303223,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":36721,"kind":"person","name":"Stergiou Angelos M.","position":1,"cik":"0001724253","reported_name":"Stergiou Angelos M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-01-14T22:34:30.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":257000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 257,000 restricted stock units on January 10, 2025, which shall vest as follows: (i) 25% on December 1, 2025 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date."}],"balance_after":615132,"source":{"system":"sec-edgar","filing":"0001104659-25-003501","document":"tm253166-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465925003501/tm253166-7_4seq1.xml","form_type":"4"}},{"id":1303232,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":46095,"kind":"person","name":"Wasman Jane","position":1,"cik":"0001352455","reported_name":"Wasman Jane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-14T22:33:29.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":18500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will fully vest on the earlier of (x) January 10, 2026 (the first anniversary of the date of grant) or (y) the business day prior to the 2026 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":18500,"derivative":{"exercise_price":0.9525,"expiration_date":"2035-01-10","underlying":"Common Stock","underlying_shares":18500},"source":{"system":"sec-edgar","filing":"0001104659-25-003498","document":"tm253166-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1352455/000110465925003498/tm253166-5_4seq1.xml","form_type":"4"}},{"id":1303231,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":46095,"kind":"person","name":"Wasman Jane","position":1,"cik":"0001352455","reported_name":"Wasman Jane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-14T22:33:29.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 12,500 restricted stock units on January 10, 2025, which shall vest in full on December 1, 2025, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":22900,"source":{"system":"sec-edgar","filing":"0001104659-25-003498","document":"tm253166-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1352455/000110465925003498/tm253166-5_4seq1.xml","form_type":"4"}},{"id":1303222,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69636,"kind":"person","name":"Kalin Katherine Bach","position":1,"cik":"0001832671","reported_name":"Kalin Katherine Bach","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-14T22:31:54.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":18500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will fully vest on the earlier of (x) January 10, 2026 (the first anniversary of the date of grant) or (y) the business day prior to the 2026 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":18500,"derivative":{"exercise_price":0.9525,"expiration_date":"2035-01-10","underlying":"Common Stock","underlying_shares":18500},"source":{"system":"sec-edgar","filing":"0001104659-25-003496","document":"tm253166-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465925003496/tm253166-3_4seq1.xml","form_type":"4"}},{"id":1303221,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69636,"kind":"person","name":"Kalin Katherine Bach","position":1,"cik":"0001832671","reported_name":"Kalin Katherine Bach","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-14T22:31:54.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 12,500 restricted stock units on January 10, 2025, which shall vest in full on December 1, 2025, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":21000,"source":{"system":"sec-edgar","filing":"0001104659-25-003496","document":"tm253166-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465925003496/tm253166-3_4seq1.xml","form_type":"4"}},{"id":1303220,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69637,"kind":"person","name":"CICIC DRAGAN","position":1,"cik":"0001565795","reported_name":"CICIC DRAGAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-14T22:30:15.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":169500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-quarter (1/4) of the option shares will vest and became exercisable one year from the January 10, 2025 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":169500,"derivative":{"exercise_price":0.9525,"expiration_date":"2035-01-10","underlying":"Common Stock","underlying_shares":169500},"source":{"system":"sec-edgar","filing":"0001104659-25-003494","document":"tm253166-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465925003494/tm253166-1_4seq1.xml","form_type":"4"}},{"id":1303219,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69637,"kind":"person","name":"CICIC DRAGAN","position":1,"cik":"0001565795","reported_name":"CICIC DRAGAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-01-14T22:30:15.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":81300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Reporting Person received an award of 81,300 restricted stock units on January 10, 2025, which shall vest in full on December 1, 2025, provided that the Reporting Person remains in service with the Issuer through each such vesting date."}],"balance_after":309628,"source":{"system":"sec-edgar","filing":"0001104659-25-003494","document":"tm253166-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465925003494/tm253166-1_4seq1.xml","form_type":"4"}},{"id":1303218,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69637,"kind":"person","name":"CICIC DRAGAN","position":1,"cik":"0001565795","reported_name":"CICIC DRAGAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-01-14T22:30:15.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":113000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 113,000 restricted stock units on January 10, 2025, which shall vest as follows: (i) 25% on December 1, 2025 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date."}],"balance_after":228328,"source":{"system":"sec-edgar","filing":"0001104659-25-003494","document":"tm253166-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465925003494/tm253166-1_4seq1.xml","form_type":"4"}},{"id":1303264,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69642,"kind":"person","name":"SCHEINBERG DAVID A","position":1,"cik":"0001250316","reported_name":"SCHEINBERG DAVID A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-14T17:34:08.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":18500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will fully vest on the earlier of (x) January 10, 2026 (the first anniversary of the date of grant) or (y) the business day prior to the 2026 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":18500,"derivative":{"exercise_price":0.9525,"expiration_date":"2035-01-10","underlying":"Common Stock","underlying_shares":18500},"source":{"system":"sec-edgar","filing":"0001104659-25-003499","document":"tm253166-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1250316/000110465925003499/tm253166-6_4seq1.xml","form_type":"4"}},{"id":1303263,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69642,"kind":"person","name":"SCHEINBERG DAVID A","position":1,"cik":"0001250316","reported_name":"SCHEINBERG DAVID A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-14T17:34:08.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 12,500 restricted stock units on January 10, 2025, which shall vest in full on December 1, 2025, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":23082,"source":{"system":"sec-edgar","filing":"0001104659-25-003499","document":"tm253166-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250316/000110465925003499/tm253166-6_4seq1.xml","form_type":"4"}},{"id":1303266,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69643,"kind":"person","name":"VAN NOSTRAND ROBERT L","position":1,"cik":"0001225198","reported_name":"VAN NOSTRAND ROBERT L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-14T17:33:03.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":18500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will fully vest on the earlier of (x) January 10, 2026 (the first anniversary of the date of grant) or (y) the business day prior to the 2026 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":18500,"derivative":{"exercise_price":0.9525,"expiration_date":"2035-01-10","underlying":"Common Stock","underlying_shares":18500},"source":{"system":"sec-edgar","filing":"0001104659-25-003497","document":"tm253166-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1225198/000110465925003497/tm253166-4_4seq1.xml","form_type":"4"}},{"id":1303265,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69643,"kind":"person","name":"VAN NOSTRAND ROBERT L","position":1,"cik":"0001225198","reported_name":"VAN NOSTRAND ROBERT L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-14T17:33:03.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 12,500 restricted stock units on January 10, 2025, which shall vest in full on December 1, 2025, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":22900,"source":{"system":"sec-edgar","filing":"0001104659-25-003497","document":"tm253166-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1225198/000110465925003497/tm253166-4_4seq1.xml","form_type":"4"}},{"id":1303352,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69656,"kind":"person","name":"Varian John","position":1,"cik":"0001416176","reported_name":"Varian John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-14T17:30:56.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":18500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will fully vest on the earlier of (x) January 10, 2026 (the first anniversary of the date of grant) or (y) the business day prior to the 2026 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":18500,"derivative":{"exercise_price":0.9525,"expiration_date":"2035-01-10","underlying":"Common Stock","underlying_shares":18500},"source":{"system":"sec-edgar","filing":"0001104659-25-003495","document":"tm253166-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1416176/000110465925003495/tm253166-2_4seq1.xml","form_type":"4"}},{"id":1303351,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69656,"kind":"person","name":"Varian John","position":1,"cik":"0001416176","reported_name":"Varian John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-14T17:30:56.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 12,500 restricted stock units on January 10, 2025, which shall vest in full on December 1, 2025, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":22900,"source":{"system":"sec-edgar","filing":"0001104659-25-003495","document":"tm253166-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1416176/000110465925003495/tm253166-2_4seq1.xml","form_type":"4"}},{"id":1341390,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69637,"kind":"person","name":"CICIC DRAGAN","position":1,"cik":"0001565795","reported_name":"CICIC DRAGAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2024-12-05T22:06:19.000Z","date":"2024-12-04","kind":"other","planned":false,"acquired":false,"shares":8256,"price":1.13,"value":9329.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction relates to shares of common stock withheld by the SELLAS Life Sciences Group, Inc. (the \"Issuer\") to cover tax withholding obligations of the Reporting Person in connection with the vesting of Restricted Stock Units (\"RSUs\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number shares of common stock withheld by the Issuer to cover tax withholding obligations of the Reporting Person in connection with the vesting of RSUs."}],"balance_after":115328,"source":{"system":"sec-edgar","filing":"0001104659-24-125944","document":"tm2430303-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465924125944/tm2430303-3_4seq1.xml","form_type":"4"}},{"id":1341389,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":36721,"kind":"person","name":"Stergiou Angelos M.","position":1,"cik":"0001724253","reported_name":"Stergiou Angelos M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-12-05T22:05:44.000Z","date":"2024-12-04","kind":"other","planned":false,"acquired":false,"shares":28289,"price":1.13,"value":31966.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction relates to shares of common stock withheld by the SELLAS Life Sciences Group, Inc. (the \"Issuer\") to cover tax withholding obligations of the Reporting Person in connection with the vesting of Restricted Stock Units (\"RSUs\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number shares of common stock withheld by the Issuer to cover tax withholding obligations of the Reporting Person in connection with the vesting of RSUs."}],"balance_after":358132,"source":{"system":"sec-edgar","filing":"0001104659-24-125943","document":"tm2430303-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465924125943/tm2430303-2_4seq1.xml","form_type":"4"}},{"id":1341388,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69638,"kind":"person","name":"Burns John Thomas","position":1,"cik":"0001568734","reported_name":"Burns John Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-12-05T22:05:10.000Z","date":"2024-12-04","kind":"other","planned":false,"acquired":false,"shares":7165,"price":1.13,"value":8096.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction relates to shares of common stock withheld by the SELLAS Life Sciences Group, Inc. (the \"Issuer\") to cover tax withholding obligations of the Reporting Person in connection with the vesting of Restricted Stock Units (\"RSUs\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number shares of common stock withheld by the Issuer to cover tax withholding obligations of the Reporting Person in connection with the vesting of RSUs."}],"balance_after":104762,"source":{"system":"sec-edgar","filing":"0001104659-24-125942","document":"tm2430303-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465924125942/tm2430303-1_4seq1.xml","form_type":"4"}},{"id":1670717,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":36721,"kind":"person","name":"Stergiou Angelos M.","position":1,"cik":"0001724253","reported_name":"Stergiou Angelos M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-25T11:04:41.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":238500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-quarter (1/4) of the option shares will vest and became exercisable one year from the January 22, 2024 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":238500,"derivative":{"exercise_price":0.5195,"expiration_date":"2034-01-22","underlying":"Common Stock","underlying_shares":238500},"source":{"system":"sec-edgar","filing":"0001104659-24-006410","document":"tm243935-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465924006410/tm243935-5_4seq1.xml","form_type":"4"}},{"id":1670716,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":36721,"kind":"person","name":"Stergiou Angelos M.","position":1,"cik":"0001724253","reported_name":"Stergiou Angelos M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-01-25T11:04:41.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":159000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 159,000 restricted stock units on January 22, 2024, which shall vest as follows: (i) 25% on December 1, 2024 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date."}],"balance_after":376421,"source":{"system":"sec-edgar","filing":"0001104659-24-006410","document":"tm243935-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465924006410/tm243935-5_4seq1.xml","form_type":"4"}},{"id":1670715,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69636,"kind":"person","name":"Kalin Katherine Bach","position":1,"cik":"0001832671","reported_name":"Kalin Katherine Bach","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-25T11:03:06.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will fully vest on the earlier of (x) January 22, 2025 (the first anniversary of the date of grant) or (y) the business day prior to the 2025 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":10000,"derivative":{"exercise_price":0.5195,"expiration_date":"2034-01-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-24-006401","document":"tm243935-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465924006401/tm243935-3_4seq1.xml","form_type":"4"}},{"id":1670714,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69636,"kind":"person","name":"Kalin Katherine Bach","position":1,"cik":"0001832671","reported_name":"Kalin Katherine Bach","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-25T11:03:06.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 6,000 restricted stock units on January 22, 2024, which shall vest in full on December 1, 2024, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":8500,"source":{"system":"sec-edgar","filing":"0001104659-24-006401","document":"tm243935-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465924006401/tm243935-3_4seq1.xml","form_type":"4"}},{"id":1670721,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":46095,"kind":"person","name":"Wasman Jane","position":1,"cik":"0001352455","reported_name":"Wasman Jane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-25T11:02:26.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will fully vest on the earlier of (x) January 22, 2025 (the first anniversary of the date of grant) or (y) the business day prior to the 2025 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":10000,"derivative":{"exercise_price":0.5195,"expiration_date":"2034-01-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-24-006397","document":"tm243935-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1352455/000110465924006397/tm243935-8_4seq1.xml","form_type":"4"}},{"id":1670720,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":46095,"kind":"person","name":"Wasman Jane","position":1,"cik":"0001352455","reported_name":"Wasman Jane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-25T11:02:26.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 6,000 restricted stock units on January 22, 2024, which shall vest in full on December 1, 2024, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":10400,"source":{"system":"sec-edgar","filing":"0001104659-24-006397","document":"tm243935-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1352455/000110465924006397/tm243935-8_4seq1.xml","form_type":"4"}},{"id":1670713,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":94897,"kind":"person","name":"Francomano Robert","position":1,"cik":"0001797467","reported_name":"Francomano Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-25T11:02:10.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-quarter (1/4) of the option shares will vest and became exercisable one year from the January 22, 2024 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":30000,"derivative":{"exercise_price":0.5195,"expiration_date":"2034-01-22","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-24-006396","document":"tm243935-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465924006396/tm243935-2_4seq1.xml","form_type":"4"}},{"id":1670712,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":94897,"kind":"person","name":"Francomano Robert","position":1,"cik":"0001797467","reported_name":"Francomano Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-01-25T11:02:10.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 20,000 restricted stock units on January 22, 2024, which shall vest as follows: (i) 25% on December 1, 2024 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date."}],"balance_after":40918,"source":{"system":"sec-edgar","filing":"0001104659-24-006396","document":"tm243935-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465924006396/tm243935-2_4seq1.xml","form_type":"4"}},{"id":1670711,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69638,"kind":"person","name":"Burns John Thomas","position":1,"cik":"0001568734","reported_name":"Burns John Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-25T11:00:13.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-quarter (1/4) of the option shares will vest and became exercisable one year from the January 22, 2024 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":75000,"derivative":{"exercise_price":0.5195,"expiration_date":"2034-01-22","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001104659-24-006379","document":"tm243935-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465924006379/tm243935-1_4seq1.xml","form_type":"4"}},{"id":1670710,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69638,"kind":"person","name":"Burns John Thomas","position":1,"cik":"0001568734","reported_name":"Burns John Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-01-25T11:00:13.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":47000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 47,000 restricted stock units on January 22, 2024, which shall vest as follows: (i) 25% on December 1, 2024 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date."}],"balance_after":101927,"source":{"system":"sec-edgar","filing":"0001104659-24-006379","document":"tm243935-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465924006379/tm243935-1_4seq1.xml","form_type":"4"}},{"id":1670742,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69642,"kind":"person","name":"SCHEINBERG DAVID A","position":1,"cik":"0001250316","reported_name":"SCHEINBERG DAVID A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-25T06:03:57.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will fully vest on the earlier of (x) January 22, 2025 (the first anniversary of the date of grant) or (y) the business day prior to the 2025 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":10000,"derivative":{"exercise_price":0.5195,"expiration_date":"2034-01-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-24-006407","document":"tm243935-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1250316/000110465924006407/tm243935-4_4seq1.xml","form_type":"4"}},{"id":1670741,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69642,"kind":"person","name":"SCHEINBERG DAVID A","position":1,"cik":"0001250316","reported_name":"SCHEINBERG DAVID A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-25T06:03:57.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 6,000 restricted stock units on January 22, 2024, which shall vest in full on December 1, 2024, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":10582,"source":{"system":"sec-edgar","filing":"0001104659-24-006407","document":"tm243935-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250316/000110465924006407/tm243935-4_4seq1.xml","form_type":"4"}},{"id":1670748,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":94898,"kind":"person","name":"WOOD BARBARA A","position":1,"cik":"0001220051","reported_name":"WOOD BARBARA A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Corp. Sec."}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-25T06:03:53.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-quarter (1/4) of the option shares will vest and became exercisable one year from the January 22, 2024 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":50000,"derivative":{"exercise_price":0.5195,"expiration_date":"2034-01-22","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-24-006405","document":"tm243935-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1220051/000110465924006405/tm243935-9_4seq1.xml","form_type":"4"}},{"id":1670747,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":94898,"kind":"person","name":"WOOD BARBARA A","position":1,"cik":"0001220051","reported_name":"WOOD BARBARA A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Corp. Sec."}}],"security":"Common Stock","published_at":"2024-01-25T06:03:53.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 35,000 restricted stock units on January 22, 2024, which shall vest as follows: (i) 25% on December 1, 2024 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date."}],"balance_after":117225,"source":{"system":"sec-edgar","filing":"0001104659-24-006405","document":"tm243935-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1220051/000110465924006405/tm243935-9_4seq1.xml","form_type":"4"}},{"id":1670844,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69656,"kind":"person","name":"Varian John","position":1,"cik":"0001416176","reported_name":"Varian John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-25T06:01:38.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will fully vest on the earlier of (x) January 22, 2025 (the first anniversary of the date of grant) or (y) the business day prior to the 2025 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":10000,"derivative":{"exercise_price":0.5195,"expiration_date":"2034-01-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-24-006392","document":"tm243935-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1416176/000110465924006392/tm243935-7_4seq1.xml","form_type":"4"}},{"id":1670843,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69656,"kind":"person","name":"Varian John","position":1,"cik":"0001416176","reported_name":"Varian John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-25T06:01:38.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 6,000 restricted stock units on January 22, 2024, which shall vest in full on December 1, 2024, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":10400,"source":{"system":"sec-edgar","filing":"0001104659-24-006392","document":"tm243935-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1416176/000110465924006392/tm243935-7_4seq1.xml","form_type":"4"}},{"id":1670746,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69643,"kind":"person","name":"VAN NOSTRAND ROBERT L","position":1,"cik":"0001225198","reported_name":"VAN NOSTRAND ROBERT L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-25T06:00:16.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will fully vest on the earlier of (x) January 22, 2025 (the first anniversary of the date of grant) or (y) the business day prior to the 2025 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":10000,"derivative":{"exercise_price":0.5195,"expiration_date":"2034-01-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-24-006381","document":"tm243935-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1225198/000110465924006381/tm243935-6_4seq1.xml","form_type":"4"}},{"id":1670745,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69643,"kind":"person","name":"VAN NOSTRAND ROBERT L","position":1,"cik":"0001225198","reported_name":"VAN NOSTRAND ROBERT L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-25T06:00:16.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 6,000 restricted stock units on January 22, 2024, which shall vest in full on December 1, 2024, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":10400,"source":{"system":"sec-edgar","filing":"0001104659-24-006381","document":"tm243935-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1225198/000110465924006381/tm243935-6_4seq1.xml","form_type":"4"}},{"id":1717562,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":36721,"kind":"person","name":"Stergiou Angelos M.","position":1,"cik":"0001724253","reported_name":"Stergiou Angelos M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2023-12-08T21:10:53.000Z","date":"2023-12-06","kind":"other","planned":false,"acquired":false,"shares":12268,"price":1.08,"value":13249.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction relates to shares of common stock withheld by SELLAS Life Sciences Group, Inc. (the \"Issuer\") to cover tax withholding obligations of the Reporting Person in connection with the vesting of Restricted Stock Units (\"RSUs\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number shares of common stock withheld by the Issuer to cover tax withholding obligations of the Reporting Person in connection with the vesting of RSUs."}],"balance_after":217421,"source":{"system":"sec-edgar","filing":"0001104659-23-124688","document":"tm2332459-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465923124688/tm2332459-3_4seq1.xml","form_type":"4"}},{"id":1717561,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":94897,"kind":"person","name":"Francomano Robert","position":1,"cik":"0001797467","reported_name":"Francomano Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2023-12-08T21:10:31.000Z","date":"2023-12-06","kind":"other","planned":false,"acquired":false,"shares":1082,"price":1.08,"value":1168.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction relates to shares of common stock withheld by SELLAS Life Sciences Group, Inc. (the \"Issuer\") to cover tax withholding obligations of the Reporting Person in connection with the vesting of Restricted Stock Units (\"RSUs\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number shares of common stock withheld by the Issuer to cover tax withholding obligations of the Reporting Person in connection with the vesting of RSUs."}],"balance_after":20918,"source":{"system":"sec-edgar","filing":"0001104659-23-124687","document":"tm2332459-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465923124687/tm2332459-2_4seq1.xml","form_type":"4"}},{"id":1717560,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69638,"kind":"person","name":"Burns John Thomas","position":1,"cik":"0001568734","reported_name":"Burns John Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Class A Common Stock","published_at":"2023-12-08T21:10:11.000Z","date":"2023-12-06","kind":"other","planned":false,"acquired":false,"shares":2929,"price":1.08,"value":3163.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction relates to shares of common stock withheld by SELLAS Life Sciences Group, Inc. (the \"Issuer\") to cover tax withholding obligations of the Reporting Person in connection with the vesting of Restricted Stock Units (\"RSUs\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number shares of common stock withheld by the Issuer to cover tax withholding obligations of the Reporting Person in connection with the vesting of RSUs."}],"balance_after":54927,"source":{"system":"sec-edgar","filing":"0001104659-23-124686","document":"tm2332459-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465923124686/tm2332459-1_4seq1.xml","form_type":"4"}},{"id":1717642,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":94898,"kind":"person","name":"WOOD BARBARA A","position":1,"cik":"0001220051","reported_name":"WOOD BARBARA A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Corp. Sec."}}],"security":"Class A Common Stock","published_at":"2023-12-08T16:11:12.000Z","date":"2023-12-06","kind":"other","planned":false,"acquired":false,"shares":4119,"price":1.08,"value":4448.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction relates to shares of common stock withheld by SELLAS Life Sciences Group, Inc. (the \"Issuer\") to cover tax withholding obligations of the Reporting Person in connection with the vesting of Restricted Stock Units (\"RSUs\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number shares of common stock withheld by the Issuer to cover tax withholding obligations of the Reporting Person in connection with the vesting of RSUs."}],"balance_after":82225,"source":{"system":"sec-edgar","filing":"0001104659-23-124690","document":"tm2332459-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1220051/000110465923124690/tm2332459-4_4seq1.xml","form_type":"4"}},{"id":2032347,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69638,"kind":"person","name":"Burns John Thomas","position":1,"cik":"0001568734","reported_name":"Burns John Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option Right to Buy)","published_at":"2023-02-03T22:17:32.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-quarter (1/4) of the option shares will vest and became exercisable one year from the February 2, 2023 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":75000,"derivative":{"exercise_price":3.34,"expiration_date":"2033-02-02","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001104659-23-010643","document":"tm235353d8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465923010643/tm235353d8_4seq1.xml","form_type":"4"}},{"id":2032346,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69638,"kind":"person","name":"Burns John Thomas","position":1,"cik":"0001568734","reported_name":"Burns John Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-02-03T22:17:32.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 20,000 restricted stock units on February 2, 2023, which shall vest as follows: (i) 25% on December 1, 2023 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date."}],"balance_after":49347,"source":{"system":"sec-edgar","filing":"0001104659-23-010643","document":"tm235353d8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465923010643/tm235353d8_4seq1.xml","form_type":"4"}},{"id":2032349,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":36721,"kind":"person","name":"Stergiou Angelos M.","position":1,"cik":"0001724253","reported_name":"Stergiou Angelos M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-03T22:15:39.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":217500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-quarter (1/4) of the option shares will vest and became exercisable one year from the February 2, 2023 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":217500,"derivative":{"exercise_price":3.34,"expiration_date":"2033-02-02","underlying":"Common Stock","underlying_shares":217500},"source":{"system":"sec-edgar","filing":"0001104659-23-010638","document":"tm235353d7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465923010638/tm235353d7_4seq1.xml","form_type":"4"}},{"id":2032348,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":36721,"kind":"person","name":"Stergiou Angelos M.","position":1,"cik":"0001724253","reported_name":"Stergiou Angelos M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-03T22:15:39.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":58000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 58,000 restricted stock units on February 2, 2023, which shall vest as follows: (i) 25% on December 1, 2023 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date.date."}],"balance_after":219689,"source":{"system":"sec-edgar","filing":"0001104659-23-010638","document":"tm235353d7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465923010638/tm235353d7_4seq1.xml","form_type":"4"}},{"id":2032345,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":94897,"kind":"person","name":"Francomano Robert","position":1,"cik":"0001797467","reported_name":"Francomano Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-03T22:14:54.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-quarter (1/4) of the option shares will vest and became exercisable one year from the February 2, 2023 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":45000,"derivative":{"exercise_price":3.34,"expiration_date":"2033-02-02","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001104659-23-010637","document":"tm235353d6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465923010637/tm235353d6_4seq1.xml","form_type":"4"}},{"id":2032344,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":94897,"kind":"person","name":"Francomano Robert","position":1,"cik":"0001797467","reported_name":"Francomano Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-02-03T22:14:54.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 12,000 restricted stock units on February 2, 2023, which shall vest as follows: (i) 25% on December 1, 2023 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date."}],"balance_after":12000,"source":{"system":"sec-edgar","filing":"0001104659-23-010637","document":"tm235353d6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465923010637/tm235353d6_4seq1.xml","form_type":"4"}},{"id":2032410,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":46095,"kind":"person","name":"Wasman Jane","position":1,"cik":"0001352455","reported_name":"Wasman Jane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-03T22:13:03.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will fully vest on the earlier of (x) February 2, 2024 (the first anniversary of the date of grant) or (y) the business day prior to the 2024 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":9500,"derivative":{"exercise_price":3.34,"expiration_date":"2033-02-02","underlying":"Common Stock","underlying_shares":9500},"source":{"system":"sec-edgar","filing":"0001104659-23-010629","document":"tm235353d4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1352455/000110465923010629/tm235353d4_4seq1.xml","form_type":"4"}},{"id":2032409,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":46095,"kind":"person","name":"Wasman Jane","position":1,"cik":"0001352455","reported_name":"Wasman Jane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-03T22:13:03.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 2,500 restricted stock units on February 2, 2023, which shall vest in full on December 1, 2023, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":4400,"source":{"system":"sec-edgar","filing":"0001104659-23-010629","document":"tm235353d4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1352455/000110465923010629/tm235353d4_4seq1.xml","form_type":"4"}},{"id":2032343,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69636,"kind":"person","name":"Kalin Katherine Bach","position":1,"cik":"0001832671","reported_name":"Kalin Katherine Bach","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-03T22:10:08.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will fully vest on the earlier of (x) February 2, 2024 (the first anniversary of the date of grant) or (y) the business day prior to the 2024 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":9500,"derivative":{"exercise_price":3.34,"expiration_date":"2033-02-02","underlying":"Common Stock","underlying_shares":9500},"source":{"system":"sec-edgar","filing":"0001104659-23-010613","document":"tm235353d1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465923010613/tm235353d1_4seq1.xml","form_type":"4"}},{"id":2032342,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69636,"kind":"person","name":"Kalin Katherine Bach","position":1,"cik":"0001832671","reported_name":"Kalin Katherine Bach","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-03T22:10:08.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 2,500 restricted stock units on February 2, 2023, which shall vest in full on December 1, 2023, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001104659-23-010613","document":"tm235353d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465923010613/tm235353d1_4seq1.xml","form_type":"4"}},{"id":2032508,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":94898,"kind":"person","name":"WOOD BARBARA A","position":1,"cik":"0001220051","reported_name":"WOOD BARBARA A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Corp. Sec."}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-03T17:18:57.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-quarter (1/4) of the option shares will vest and became exercisable one year from the February 2, 2023 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":80000,"derivative":{"exercise_price":3.34,"expiration_date":"2033-02-02","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001104659-23-010654","document":"tm235353d9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1220051/000110465923010654/tm235353d9_4seq1.xml","form_type":"4"}},{"id":2032507,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":94898,"kind":"person","name":"WOOD BARBARA A","position":1,"cik":"0001220051","reported_name":"WOOD BARBARA A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Corp. Sec."}}],"security":"Common Stock","published_at":"2023-02-03T17:18:57.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 20,000 restricted stock units on February 2, 2023, which shall vest as follows: (i) 25% on December 1, 2023 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date."}],"balance_after":76344,"source":{"system":"sec-edgar","filing":"0001104659-23-010654","document":"tm235353d9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1220051/000110465923010654/tm235353d9_4seq1.xml","form_type":"4"}},{"id":2032703,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69656,"kind":"person","name":"Varian John","position":1,"cik":"0001416176","reported_name":"Varian John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-03T17:14:07.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will fully vest on the earlier of (x) February 2, 2024 (the first anniversary of the date of grant) or (y) the business day prior to the 2024 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":9500,"derivative":{"exercise_price":3.34,"expiration_date":"2033-02-02","underlying":"Common Stock","underlying_shares":9500},"source":{"system":"sec-edgar","filing":"0001104659-23-010635","document":"tm235353d5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1416176/000110465923010635/tm235353d5_4seq1.xml","form_type":"4"}},{"id":2032702,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69656,"kind":"person","name":"Varian John","position":1,"cik":"0001416176","reported_name":"Varian John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-03T17:14:07.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 2,500 restricted stock units on February 2, 2023, which shall vest in full on December 1, 2023, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":4400,"source":{"system":"sec-edgar","filing":"0001104659-23-010635","document":"tm235353d5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1416176/000110465923010635/tm235353d5_4seq1.xml","form_type":"4"}},{"id":2032506,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69643,"kind":"person","name":"VAN NOSTRAND ROBERT L","position":1,"cik":"0001225198","reported_name":"VAN NOSTRAND ROBERT L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-03T17:11:52.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will fully vest on the earlier of (x) February 2, 2024 (the first anniversary of the date of grant) or (y) the business day prior to the 2024 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":9500,"derivative":{"exercise_price":3.34,"expiration_date":"2033-02-02","underlying":"Common Stock","underlying_shares":9500},"source":{"system":"sec-edgar","filing":"0001104659-23-010623","document":"tm235353d3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1225198/000110465923010623/tm235353d3_4seq1.xml","form_type":"4"}},{"id":2032505,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69643,"kind":"person","name":"VAN NOSTRAND ROBERT L","position":1,"cik":"0001225198","reported_name":"VAN NOSTRAND ROBERT L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-03T17:11:52.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 2,500 restricted stock units on February 2, 2023, which shall vest in full on December 1, 2023, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":4400,"source":{"system":"sec-edgar","filing":"0001104659-23-010623","document":"tm235353d3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1225198/000110465923010623/tm235353d3_4seq1.xml","form_type":"4"}},{"id":2032501,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69642,"kind":"person","name":"SCHEINBERG DAVID A","position":1,"cik":"0001250316","reported_name":"SCHEINBERG DAVID A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-03T17:11:05.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will fully vest on the earlier of (x) February 2, 2024 (the first anniversary of the date of grant) or (y) the business day prior to the 2024 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":9500,"derivative":{"exercise_price":3.34,"expiration_date":"2033-02-02","underlying":"Common Stock","underlying_shares":9500},"source":{"system":"sec-edgar","filing":"0001104659-23-010619","document":"tm235353d2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1250316/000110465923010619/tm235353d2_4seq1.xml","form_type":"4"}},{"id":2032500,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69642,"kind":"person","name":"SCHEINBERG DAVID A","position":1,"cik":"0001250316","reported_name":"SCHEINBERG DAVID A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-03T17:11:05.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 2,500 restricted stock units on February 2, 2023, which shall vest in full on December 1, 2023, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":4582,"source":{"system":"sec-edgar","filing":"0001104659-23-010619","document":"tm235353d2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250316/000110465923010619/tm235353d2_4seq1.xml","form_type":"4"}},{"id":2095703,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":36721,"kind":"person","name":"Stergiou Angelos M.","position":1,"cik":"0001724253","reported_name":"Stergiou Angelos M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2022-12-05T21:14:34.000Z","date":"2022-12-05","kind":"sale","acquired":false,"shares":6494,"price":2.6083,"value":16938.3002,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reflects the weighted average sale price of the shares of common stock sold. These shares of common stock were sold in multiple transactions at prices ranging from $2.58 to $2.66, inclusive, per share of common stock. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares of common stock sold at each price."}],"balance_after":161689,"source":{"system":"sec-edgar","filing":"0001104659-22-124568","document":"tm2232008-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465922124568/tm2232008-3_4seq1.xml","form_type":"4"}},{"id":2095702,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69638,"kind":"person","name":"Burns John Thomas","position":1,"cik":"0001568734","reported_name":"Burns John Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance & CAO"}}],"security":"Class A Common Stock","published_at":"2022-12-05T21:13:38.000Z","date":"2022-12-05","kind":"sale","acquired":false,"shares":1159,"price":2.59,"value":3001.81,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":29347,"source":{"system":"sec-edgar","filing":"0001104659-22-124566","document":"tm2232008-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465922124566/tm2232008-2_4seq1.xml","form_type":"4"}},{"id":2095781,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":94898,"kind":"person","name":"WOOD BARBARA A","position":1,"cik":"0001220051","reported_name":"WOOD BARBARA A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Corp. Sec."}}],"security":"Class A Common Stock","published_at":"2022-12-05T16:12:54.000Z","date":"2022-12-05","kind":"sale","acquired":false,"shares":2153,"price":2.59,"value":5576.27,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":56344,"source":{"system":"sec-edgar","filing":"0001104659-22-124565","document":"tm2232008-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1220051/000110465922124565/tm2232008-1_4seq1.xml","form_type":"4"}},{"id":2183747,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69636,"kind":"person","name":"Kalin Katherine Bach","position":1,"cik":"0001832671","reported_name":"Kalin Katherine Bach","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-16T20:08:20.000Z","date":"2022-08-13","kind":"grant","acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will fully vest on August 13, 2023."}],"balance_after":19000,"derivative":{"exercise_price":3.1,"expiration_date":"2032-08-13","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001104659-22-091751","document":"tm2223585-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465922091751/tm2223585-1_4seq1.xml","form_type":"4"}},{"id":2332854,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":94897,"kind":"person","name":"Francomano Robert","position":1,"cik":"0001797467","reported_name":"Francomano Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-15T20:05:52.000Z","date":"2022-03-14","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-quarter (1/4) of the option shares will vest and became exercisable one year from the March 14, 2022 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter."}],"balance_after":100000,"derivative":{"exercise_price":5.23,"expiration_date":"2032-03-14","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-22-033927","document":"tm229354-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465922033927/tm229354-1_4seq1.xml","form_type":"4"}},{"id":2418925,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":46095,"kind":"person","name":"Wasman Jane","position":1,"cik":"0001352455","reported_name":"Wasman Jane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-01T22:07:08.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":7125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will fully vest on the earlier of (x) January 31, 2023 (the first anniversary of the date of grant) or (y) the business day prior to the 2023 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":7125,"derivative":{"exercise_price":5.34,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":7125},"source":{"system":"sec-edgar","filing":"0001104659-22-010400","document":"tm225088-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1352455/000110465922010400/tm225088-6_4seq1.xml","form_type":"4"}},{"id":2418924,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":46095,"kind":"person","name":"Wasman Jane","position":1,"cik":"0001352455","reported_name":"Wasman Jane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-01T22:07:08.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":1900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 1,900 restricted stock units on January 31, 2022, which shall vest in full on December 1, 2022, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":1900,"source":{"system":"sec-edgar","filing":"0001104659-22-010400","document":"tm225088-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1352455/000110465922010400/tm225088-6_4seq1.xml","form_type":"4"}},{"id":2418899,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":36721,"kind":"person","name":"Stergiou Angelos M.","position":1,"cik":"0001724253","reported_name":"Stergiou Angelos M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-01T22:06:24.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":165000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-quarter (1/4) of the option shares will vest and became exercisable one year from the January 31, 2022 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":165000,"derivative":{"exercise_price":5.34,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":165000},"source":{"system":"sec-edgar","filing":"0001104659-22-010396","document":"tm225088-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465922010396/tm225088-3_4seq1.xml","form_type":"4"}},{"id":2418898,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":36721,"kind":"person","name":"Stergiou Angelos M.","position":1,"cik":"0001724253","reported_name":"Stergiou Angelos M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-02-01T22:06:24.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 44,000 restricted stock units on January 31, 2022, which shall vest as follows: (i) 25% on December 1, 2022 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date."}],"balance_after":165167,"source":{"system":"sec-edgar","filing":"0001104659-22-010396","document":"tm225088-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465922010396/tm225088-3_4seq1.xml","form_type":"4"}},{"id":2418897,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69638,"kind":"person","name":"Burns John Thomas","position":1,"cik":"0001568734","reported_name":"Burns John Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance & CAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-01T22:05:11.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-quarter (1/4) of the option shares will vest and became exercisable one year from the January 31, 2022 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":36000,"derivative":{"exercise_price":5.34,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001104659-22-010391","document":"tm225088-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465922010391/tm225088-1_4seq1.xml","form_type":"4"}},{"id":2418896,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69638,"kind":"person","name":"Burns John Thomas","position":1,"cik":"0001568734","reported_name":"Burns John Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance & CAO"}}],"security":"Common Stock","published_at":"2022-02-01T22:05:11.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":9600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 9,600 restricted stock units on January 31, 2022, which shall vest as follows: (i) 25% on December 1, 2022 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date."}],"balance_after":27244,"source":{"system":"sec-edgar","filing":"0001104659-22-010391","document":"tm225088-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465922010391/tm225088-1_4seq1.xml","form_type":"4"}},{"id":2418969,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":94898,"kind":"person","name":"WOOD BARBARA A","position":1,"cik":"0001220051","reported_name":"WOOD BARBARA A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Corp. Sec."}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-01T17:07:57.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":48750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-quarter (1/4) of the option shares will vest and became exercisable one year from the January 31, 2022 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":48750,"derivative":{"exercise_price":5.34,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":48750},"source":{"system":"sec-edgar","filing":"0001104659-22-010401","document":"tm225088-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1220051/000110465922010401/tm225088-7_4seq1.xml","form_type":"4"}},{"id":2418968,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":94898,"kind":"person","name":"WOOD BARBARA A","position":1,"cik":"0001220051","reported_name":"WOOD BARBARA A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Corp. Sec."}}],"security":"Common Stock","published_at":"2022-02-01T17:07:57.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 13,000 restricted stock units on January 31, 2022, which shall vest as follows: (i) 25% on December 1, 2022 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date."}],"balance_after":55028,"source":{"system":"sec-edgar","filing":"0001104659-22-010401","document":"tm225088-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1220051/000110465922010401/tm225088-7_4seq1.xml","form_type":"4"}},{"id":2419133,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69656,"kind":"person","name":"Varian John","position":1,"cik":"0001416176","reported_name":"Varian John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-01T17:06:51.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":7125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will fully vest on the earlier of (x) January 31, 2023 (the first anniversary of the date of grant) or (y) the business day prior to the 2023 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":7125,"derivative":{"exercise_price":5.34,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":7125},"source":{"system":"sec-edgar","filing":"0001104659-22-010399","document":"tm225088-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1416176/000110465922010399/tm225088-5_4seq1.xml","form_type":"4"}},{"id":2419132,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69656,"kind":"person","name":"Varian John","position":1,"cik":"0001416176","reported_name":"Varian John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-01T17:06:51.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":1900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 1,900 restricted stock units on January 31, 2022, which shall vest in full on December 1, 2022, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":1900,"source":{"system":"sec-edgar","filing":"0001104659-22-010399","document":"tm225088-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1416176/000110465922010399/tm225088-5_4seq1.xml","form_type":"4"}},{"id":2418967,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69643,"kind":"person","name":"VAN NOSTRAND ROBERT L","position":1,"cik":"0001225198","reported_name":"VAN NOSTRAND ROBERT L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-01T17:06:44.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":7125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will fully vest on the earlier of (x) January 31, 2023 (the first anniversary of the date of grant) or (y) the business day prior to the 2023 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":7125,"derivative":{"exercise_price":5.34,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":7125},"source":{"system":"sec-edgar","filing":"0001104659-22-010397","document":"tm225088-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1225198/000110465922010397/tm225088-4_4seq1.xml","form_type":"4"}},{"id":2418966,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69643,"kind":"person","name":"VAN NOSTRAND ROBERT L","position":1,"cik":"0001225198","reported_name":"VAN NOSTRAND ROBERT L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-01T17:06:44.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":1900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 1,900 restricted stock units on January 31, 2022, which shall vest in full on December 1, 2022, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":1900,"source":{"system":"sec-edgar","filing":"0001104659-22-010397","document":"tm225088-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1225198/000110465922010397/tm225088-4_4seq1.xml","form_type":"4"}},{"id":2418962,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69642,"kind":"person","name":"SCHEINBERG DAVID A","position":1,"cik":"0001250316","reported_name":"SCHEINBERG DAVID A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-01T17:05:46.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":7125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will fully vest on the earlier of (x) January 31, 2023 (the first anniversary of the date of grant) or (y) the business day prior to the 2023 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":7125,"derivative":{"exercise_price":5.34,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":7125},"source":{"system":"sec-edgar","filing":"0001104659-22-010393","document":"tm225088-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1250316/000110465922010393/tm225088-2_4seq1.xml","form_type":"4"}},{"id":2418961,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69642,"kind":"person","name":"SCHEINBERG DAVID A","position":1,"cik":"0001250316","reported_name":"SCHEINBERG DAVID A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-01T17:05:46.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":1900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 1,900 restricted stock units on January 31, 2022, which shall vest in full on December 1, 2022, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":2082,"source":{"system":"sec-edgar","filing":"0001104659-22-010393","document":"tm225088-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1250316/000110465922010393/tm225088-2_4seq1.xml","form_type":"4"}},{"id":2485192,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":36721,"kind":"person","name":"Stergiou Angelos M.","position":1,"cik":"0001724253","reported_name":"Stergiou Angelos M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-12-03T22:15:02.000Z","date":"2021-12-02","kind":"sale","acquired":false,"shares":2120,"price":6.2509,"value":13251.908,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs.  The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reflects the weighted average sale price of the shares of common stock sold. These shares of common stock were sold in multiple transactions at prices ranging from $6.25 to $6.27, inclusive, per share of common stock. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares of common stock sold at each price."}],"balance_after":121167,"source":{"system":"sec-edgar","filing":"0001104659-21-146424","document":"tm2134552-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465921146424/tm2134552-6_4seq1.xml","form_type":"4"}},{"id":2485191,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":69638,"kind":"person","name":"Burns John Thomas","position":1,"cik":"0001568734","reported_name":"Burns John Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance & Corp Controller"}}],"security":"Common Stock","published_at":"2021-12-03T22:13:33.000Z","date":"2021-12-02","kind":"sale","acquired":false,"shares":231,"price":6.2673,"value":1447.7463,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs.  The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reflects the weighted average sale price of the shares of common stock sold. These shares of common stock were sold in multiple transactions at prices ranging from $6.25 to $6.27, inclusive, per share of common stock. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares of common stock sold at each price."}],"balance_after":17644,"source":{"system":"sec-edgar","filing":"0001104659-21-146421","document":"tm2134552-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465921146421/tm2134552-4_4seq1.xml","form_type":"4"}},{"id":2485239,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":94898,"kind":"person","name":"WOOD BARBARA A","position":1,"cik":"0001220051","reported_name":"WOOD BARBARA A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Corp. Sec."}}],"security":"Common Stock","published_at":"2021-12-03T17:14:06.000Z","date":"2021-12-02","kind":"sale","acquired":false,"shares":847,"price":6.2547,"value":5297.7309,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs.  The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reflects the weighted average sale price of the shares of common stock sold. These shares of common stock were sold in multiple transactions at prices ranging from $6.25 to $6.27, inclusive, per share of common stock. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares of common stock sold at each price."}],"balance_after":42028,"source":{"system":"sec-edgar","filing":"0001104659-21-146422","document":"tm2134552-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1220051/000110465921146422/tm2134552-5_4seq1.xml","form_type":"4"}},{"id":2802717,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":46095,"kind":"person","name":"Wasman Jane","position":1,"cik":"0001352455","reported_name":"Wasman Jane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-08T21:29:16.000Z","date":"2021-03-04","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will fully vest on the earlier of (x) March 4, 2022 (the first anniversary of the date of grant) or (y) the business day prior to the 2022 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date."}],"balance_after":7500,"derivative":{"exercise_price":8,"expiration_date":"2031-03-04","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001104659-21-033298","document":"tm218923d5_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1352455/000110465921033298/tm218923d5_4.xml","form_type":"4"}}],"next_cursor":"2021-03-08T21:29:16.000000Z,2802717"}